Disease | colorectal cancer |
Phenotype | |liver metastases |
Sentences | 110 |
PubMedID- 21489291 | This trial focuses on patients with resectable liver metastases of colorectal cancer. |
PubMedID- 25465375 | Background: a phase ii clinical trial was conducted on colorectal cancer patients with only liver metastases (focal diameter exceeds 5 cm or the number of liver metastases is >/=5; h2.h3) to evaluate the liver resection rate and safety after 6 cycles of mfolfox6+bevacizumab (bv) therapy. |
PubMedID- 24755295 | In this study, mirna profiles between five colorectal cancer tissues with synchronous liver metastases and five colorectal cancer tissues without liver metastases were compared. |
PubMedID- 24800922 | Folfiri and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a cesar phase ii study including pharmacokinetic, biomarker, and imaging data. |
PubMedID- 22739844 | Introduction: for colorectal cancer patients with liver metastases involving the hepatic dome or invading the diaphragm, a concomitant diaphragm resection is often required to achieve negative surgical margins. |
PubMedID- 20108150 | Background: hepatectomy may prolong the survival of colorectal cancer patients with liver metastases. |
PubMedID- 24742404 | colorectal cancer with liver metastases -- is there a chance for cure. |
PubMedID- 21174058 | Microrna expression profiles in human colorectal cancers with liver metastases. |
PubMedID- 21819613 | 54 years-old male patient who received 1.7 gbq y-90 microsphere therapy to the right and left lobes in separate sessions for liver metastases of colorectal cancer. |
PubMedID- 22460570 | The purpose of the present study was to determine whether there were differences in outcome between rfa and surgical resection in the treatment of colorectal cancer with liver metastases. |